Lifsar PulmoJet

Medicinal product

(Invented) name

Lifsar PulmoJet

Active substance (s)

Salmeterolis/Flutikazonas

Strength

50 µg/500 µg/dozėje

Pharmaceutical form

įkvepiamieji milteliai

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03AK06, Salmeterol and fluticasone

Marketing authorisation holder

Zentiva k.s., Čekija

Date of authorisation

2016-06-08

Date of renewal

Documents

3926_1 Lifsar PulmoJet RPP 170616.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

UK/H/5582/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Dozėje yra	1 dozėje
Salmeterolis	50 µg
Flutikazonas	500 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
58954	73173	1073173	inhaliatorius	60 dozių N1		Receptinis	LT/1/16/3926/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-12-05	Išregistruotas
2016-06-08	Registruotas